Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2016 May;101(3):F201-6.
doi: 10.1136/archdischild-2015-308899. Epub 2015 Nov 13.

Early blood pressure, antihypotensive therapy and outcomes at 18-22 months' corrected age in extremely preterm infants

Beau Batton  1 , Lei Li  2 , Nancy S Newman  3 , Abhik Das  4 , Kristi L Watterberg  5 , Bradley A Yoder  6 , Roger G Faix  6 , Matthew M Laughon  7 , Barbara J Stoll  8 , Rosemary D Higgins  9 , Michele C Walsh  3 ; Eunice Kennedy Shriver National Institute of Child Health & Human Development Neonatal Research Network
Affiliations
Observational Study

Early blood pressure, antihypotensive therapy and outcomes at 18-22 months' corrected age in extremely preterm infants

Beau Batton et al. Arch Dis Child Fetal Neonatal Ed. 2016 May.

Abstract

Objective: To investigate the relationships between early blood pressure (BP) changes, receipt of antihypotensive therapy and 18-22 months' corrected age (CA) outcomes for extremely preterm infants.

Design: Prospective observational study of infants 23(0/7)-26(6/7) weeks' gestational age (GA). Hourly BP values and antihypotensive therapy exposure in the first 24 h were recorded. Four groups were defined: infants who did or did not receive antihypotensive therapy in whom BP did or did not rise at the expected rate (defined as an increase in the mean arterial BP of ≥5 mm Hg/day). Random-intercept logistic modelling controlling for centre clustering, GA and illness severity was used to investigate the relationship between BP, antihypotensive therapies and infant outcomes.

Setting: Sixteen academic centres of the Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network.

Main outcome measures: Death or neurodevelopmental impairment/developmental delay (NIDD) at 18-22 months' CA.

Results: Of 367 infants, 203 (55%) received an antihypotensive therapy, 272 (74%) survived to discharge and 331 (90%) had a known outcome at 18-22 months' CA. With logistic regression, there was an increased risk of death/NIDD with antihypotensive therapy versus no treatment (OR 1.836, 95% CI 1.092 to 3.086), but not NIDD alone (OR 1.53, 95% CI 0.708 to 3.307).

Conclusions: Independent of early BP changes, antihypotensive therapy exposure was associated with an increased risk of death/NIDD at 18-22 months' CA when controlling for risk factors known to affect survival and neurodevelopment.

Clinical trial registration number: clinicaltrials.gov #NCT00874393.

Keywords: Cardiology; Neonatology; Neurodevelopment.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Extremely preterm infant study enrollment classified by study group; NICU = neonatal intensive care unit; BP = blood pressure; ND = neurodevelopmental
See this image and copyright information in PMC

Comment in

References

    1. Watkins A, West C, Cooke R. Blood pressure and cerebral haemorrhage and ischaemia in very low birthweight infants. Early Hum Dev. 1989;19:103–110. - PubMed
    1. Cunningham S, Symon A, Elton R, et al. Intra-arterial blood pressure reference ranges, death and morbidity in very low birthweight infants during the first seven days of life. Early Hum Dev. 1999;56:151–165. - PubMed
    1. Short B, Van Meurs K, Evans J. Summary proceedings from the cardiology group on cardiovascular instability in preterm infants. Pediatrics. 2006;117:S34–S39. - PubMed
    1. Lundstrom K, Pryds O, Greisen G. The haemodynamic effects of dopamine and volume expansion in sick preterm infants. Early Hum Dev. 2000;57:157–163. - PubMed
    1. Batton B, Batton D, Riggs T. Blood pressure in the first 7 days in premature infants born at postmenstrual age 23 to 25 weeks. Am J Perinatol. 2007;24:107–115. - PubMed

Publication types

MeSH terms

Associated data